Bonus BioGroup Ltd.
BBIXF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $235 | $77,485 | $50,752 | $151,569 |
| - Cash | $1,197 | $1,197 | $6,859 | $8,732 |
| + Debt | $9,603 | $9,603 | $10,192 | $10,556 |
| Enterprise Value | $8,641 | $85,891 | $54,085 | $153,393 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5,442 | -$5,442 | -$4,984 | -$5,993 |
| % Margin | – | – | – | – |
| Net Income | -$6,334 | -$6,334 | -$5,860 | -$6,988 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.009 | -0.009 | -0.008 | -0.006 |
| % Growth | 0% | -13.8% | -33.3% | – |
| Operating Cash Flow | -$4,024 | -$4,024 | -$4,427 | -$5,828 |
| Capital Expenditures | -$2 | -$2 | -$22 | -$56 |
| Free Cash Flow | -$4,026 | -$4,026 | -$4,449 | -$5,884 |